21 – 30 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study
- Contribution to journal › Article
-
Mark
Arsenic trioxide is a novel agent for combination therapy to prolong heart allograft survival in allo-primed T cells transferred mice
- Contribution to journal › Article
- 2010
-
Mark
Is Rituximab Safe to Use in Kidney Transplant Patients?
- Contribution to journal › Letter
-
Mark
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study
- Contribution to journal › Article
-
Mark
An N-(alkylcarbonyl)anthranilic acid derivative prolongs cardiac allograft survival synergistically with cyclosporine A in a high-responder rat model
- Contribution to journal › Article
-
Mark
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
- Contribution to journal › Article
-
Mark
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
(2010) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 25. p.2004-2010
- Contribution to journal › Article
-
Mark
Renal Transplant Patients at High Risk of Acute Rejection Benefit From Adequate Exposure to Mycophenolic Acid.
- Contribution to journal › Article
-
Mark
Small Islets are Essential for Successful Intraportal Transplantation in a Diabetes Mouse Model
- Contribution to journal › Article
-
Mark
Authors' Reply to Letter by van den Hoogen and Hilbrands
- Contribution to journal › Letter